SUMO rules: Regulatory concepts and their implication in neurologic functions

NeuroMolecular Medicine

Volumn 15, Issue 4, 2013, Pages 639-660

  Droescher, Mathias ^a   Chaugule, Viduth K ^a   Pichler, Andrea ^a  

^a MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

Author keywords

Deregulation; E1 activating enzyme; E2 conjugating enzyme; E3 ligases; Neurological disorders; SIM; SUMO; SUMO consensus; SUMO paralogs; SUMO specific proteases

Indexed keywords

SUMO PROTEIN; UBIQUITIN CONJUGATING ENZYME E2; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE E1; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

CELL CYCLE REGULATION; CELL NUCLEUS TRANSPLANTATION; DNA REPAIR; GENETIC ORGANIZATION; NERVE CELL PLASTICITY; NERVE DEGENERATION; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MOTIF; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SUMOYLATION; SYNAPTIC TRANSMISSION;

AMINO ACID MOTIFS; ANIMALS; CELL HYPOXIA; CONSENSUS SEQUENCE; CYSTEINE ENDOPEPTIDASES; DNA REPAIR; GENE EXPRESSION REGULATION; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MODELS, MOLECULAR; NERVE DEGENERATION; NERVE TISSUE PROTEINS; NERVOUS SYSTEM DISEASES; NERVOUS SYSTEM PHYSIOLOGICAL PROCESSES; PROTEIN CONFORMATION; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; SUMOYLATION; UBIQUITIN-PROTEIN LIGASE COMPLEXES;

EID: 84888198951     PISSN: 15351084     EISSN: 15591174     Source Type: Journal    
DOI: 10.1007/s12017-013-8258-6     Document Type: Review

References (270)

1. Andrews, E. A.; Palecek, J.; Sergeant, J.; Taylor, E.; Lehmann, A. R.; Watts, F. Z. (2005). Nse2, a component of the Smc5-6 complex, is a SUMO ligase required for the response to DNA damage. Molecular and Cellular Biology, 25(1), 185-196.
2. Aslanukov, A.; Bhowmick, R.; Guruju, M.; Oswald, J.; Raz, D.; Bush, R. A.; et al. (2006). RanBP2 modulates Cox11 and hexokinase I activities and haploinsufficiency of RanBP2 causes deficits in glucose metabolism. PLoS Genetics, 2(10), e177.
3. Azuma, Y.; Arnaoutov, A.; Anan, T.; Dasso, M. (2005). PIASy mediates SUMO-2 conjugation of Topoisomerase-II on mitotic chromosomes. EMBO Journal, 24(12), 2172-2182.
4. Bachant, J.; Alcasabas, A.; Blat, Y.; Kleckner, N.; Elledge, S. J. (2002). The SUMO-1 isopeptidase Smt4 is linked to centromeric cohesion through SUMO-1 modification of DNA topoisomerase II. Molecular Cell, 9(6), 1169-1182.
5. Bailey, D.; O'Hare, P. (2002). Herpes simplex virus 1 ICP0 co-localizes with a SUMO-specific protease. Journal of General Virology, 83(Pt 12), 2951-2964.
6. Baldwin, M. L.; Julius, J. A.; Tang, X.; Wang, Y.; Bachant, J. (2009). The yeast SUMO isopeptidase Smt4/Ulp2 and the polo kinase Cdc5 act in an opposing fashion to regulate sumoylation in mitosis and cohesion at centromeres. Cell Cycle, 8(20), 3406-3419.
7. Bayer, P.; Arndt, A.; Metzger, S.; Mahajan, R.; Melchior, F.; Jaenicke, R.; et al. (1998). Structure determination of the small ubiquitin-related modifier SUMO-1. Journal of Molecular Biology, 280(2), 275-286.
8. Bencsath, K. P.; Podgorski, M. S.; Pagala, V. R.; Slaughter, C. A.; Schulman, B. A. (2002). Identification of a multifunctional binding site on Ubc9p required for Smt3p conjugation. Journal of Biological Chemistry, 277(49), 47938-47945.
9. Bernier-Villamor, V.; Sampson, D. A.; Matunis, M. J.; Lima, C. D. (2002). Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1. Cell, 108(3), 345-356.
10. Bettermann, K.; Benesch, M.; Weis, S.; Haybaeck, J. (2012). SUMOylation in carcinogenesis. Cancer Letters, 316(2), 113-125.
11. Blomster, H. A.; Imanishi, S. Y.; Siimes, J.; Kastu, J.; Morrice, N. A.; Eriksson, J. E.; et al. (2010). In vivo identification of sumoylation sites by a signature tag and cysteine-targeted affinity purification. Journal of Biological Chemistry, 285(25), 19324-19329.
12. Boggio, R.; Colombo, R.; Hay, R. T.; Draetta, G. F.; Chiocca, S. (2004). A mechanism for inhibiting the SUMO pathway. Molecular Cell, 16(4), 549-561.
13. Boggio, R.; Passafaro, A.; Chiocca, S. (2007). Targeting SUMO E1 to ubiquitin ligases: a viral strategy to counteract sumoylation. Journal of Biological Chemistry, 282(21), 15376-15382.
14. Bohren, K. M.; Nadkarni, V.; Song, J. H.; Gabbay, K. H.; Owerbach, D. (2004). A M55 V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus. Journal of Biological Chemistry, 279(26), 27233-27238.
15. Bossis, G.; Melchior, F. (2006). Regulation of SUMOylation by reversible oxidation of SUMO conjugating enzymes. Molecular Cell, 21(3), 349-357.
16. Branzei, D.; Sollier, J.; Liberi, G.; Zhao, X.; Maeda, D.; Seki, M.; et al. (2006). Ubc9- and mms21-mediated sumoylation counteracts recombinogenic events at damaged replication forks. Cell, 127(3), 509-522.
17. Braschi, E.; Zunino, R.; McBride, H. M. (2009). MAPL is a new mitochondrial SUMO E3 ligase that regulates mitochondrial fission. EMBO Reports, 10(7), 748-754.
18. Bruderer, R.; Tatham, M. H.; Plechanovova, A.; Matic, I.; Garg, A. K.; Hay, R. T. (2011). Purification and identification of endogenous polySUMO conjugates. EMBO Reports, 12(2), 142-148.
19. Burgess, R. C.; Rahman, S.; Lisby, M.; Rothstein, R.; Zhao, X. (2007). The Slx5-Slx8 complex affects sumoylation of DNA repair proteins and negatively regulates recombination. Molecular and Cellular Biology, 27(17), 6153-6162.
20. Burn, B.; Brown, S.; Chang, C. (2011). Regulation of early Xenopus development by the PIAS genes. Developmental Dynamics, 240(9), 2120-2126.
21. Cai, Q.; Verma, S. C.; Kumar, P.; Ma, M.; Robertson, E. S. (2010). Hypoxia inactivates the VHL tumor suppressor through PIASy-mediated SUMO modification. PLoS ONE, 5(3), e9720.
22. Capili, A. D.; Lima, C. D. (2007). Structure and analysis of a complex between SUMO and Ubc9 illustrates features of a conserved E2-Ubl interaction. Journal of Molecular Biology, 369(3), 608-618.
23. Castillo-Lluva, S.; Tatham, M. H.; Jones, R. C.; Jaffray, E. G.; Edmondson, R. D.; Hay, R. T.; et al. (2010). SUMOylation of the GTPase Rac1 is required for optimal cell migration. Nature Cell Biology, 12(11), 1078-1085.
24. Chan, D. C. (2012). Fusion and fission: interlinked processes critical for mitochondrial health. Annual Review of Genetics, 46, 265-287.
25. Chang, C. C.; Naik, M. T.; Huang, Y. S.; Jeng, J. C.; Liao, P. H.; Kuo, H. Y.; et al. (2011). Structural and functional roles of Daxx SIM phosphorylation in SUMO paralog-selective binding and apoptosis modulation. Molecular Cell, 42(1), 62-74.
26. Chen, S. F.; Gong, C.; Luo, M.; Yao, H. R.; Zeng, Y. J.; Su, F. X. (2011). Ubc9 expression predicts chemoresistance in breast cancer. Chin J Cancer, 30(9), 638-644.
27. Chen, X. L.; Silver, H. R.; Xiong, L.; Belichenko, I.; Adegite, C.; Johnson, E. S. (2007). Topoisomerase I-dependent viability loss in saccharomyces cerevisiae mutants defective in both SUMO conjugation and DNA repair. Genetics, 177(1), 17-30.
28. Cheng, J.; Kang, X.; Zhang, S.; Yeh, E. T. (2007). SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia. Cell, 131(3), 584-595.
29. Cheng, C. H.; Lo, Y. H.; Liang, S. S.; Ti, S. C.; Lin, F. M.; Yeh, C. H.; et al. (2006). SUMO modifications control assembly of synaptonemal complex and polycomplex in meiosis of Saccharomyces cerevisiae. Genes & Development, 20(15), 2067-2081.
30. Chiu, S. Y.; Asai, N.; Costantini, F.; Hsu, W. (2008). SUMO-specific protease 2 is essential for modulating p53-Mdm2 in development of trophoblast stem cell niches and lineages. PLoS Biology, 6(12), e310.
31. Cho, K. I.; Searle, K.; Webb, M.; Yi, H.; Ferreira, P. A. (2012). Ranbp2 haploinsufficiency mediates distinct cellular and biochemical phenotypes in brain and retinal dopaminergic and glia cells elicited by the Parkinsonian neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Cellular and Molecular Life Sciences, 69(20), 3511-3527.
32. Chu, Y.; Yang, X. (2011). SUMO E3 ligase activity of TRIM proteins. Oncogene, 30(9), 1108-1116.
33. Cimarosti, H.; Lindberg, C.; Bomholt, S. F.; Ronn, L. C.; Henley, J. M. (2008). Increased protein SUMOylation following focal cerebral ischemia. Neuropharmacology, 54(2), 280-289.
34. Comerford, K. M.; Leonard, M. O.; Karhausen, J.; Carey, R.; Colgan, S. P.; Taylor, C. T. (2003). Small ubiquitin-related modifier-1 modification mediates resolution of CREB-dependent responses to hypoxia. Proceedings of National Academy of Sciences of the United States of America, 100(3), 986-991.
35. Cubenas-Potts, C.; Matunis, M. J. (2013). SUMO: A multifaceted modifier of chromatin structure and function. Developmental Cell, 24(1), 1-12.
36. Danielsen, J. R.; Povlsen, L. K.; Villumsen, B. H.; Streicher, W.; Nilsson, J.; Wikstrom, M.; et al. (2012). DNA damage-inducible SUMOylation of HERC2 promotes RNF8 binding via a novel SUMO-binding Zinc finger. Journal of Cell Biology, 197(2), 179-187.
37. Datwyler, A. L.; Lattig-Tunnemann, G.; Yang, W.; Paschen, W.; Lee, S. L.; Dirnagl, U.; et al. (2011). SUMO2/3 conjugation is an endogenous neuroprotective mechanism. Journal of Cerebral Blood Flow and Metabolism, 31(11), 2152-2159.
38. Dawlaty, M. M.; Malureanu, L.; Jeganathan, K. B.; Kao, E.; Sustmann, C.; Tahk, S.; et al. (2008). Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. Cell, 133(1), 103-115.
39. Depaux, A.; Regnier-Ricard, F.; Germani, A.; Varin-Blank, N. (2007). A crosstalk between hSiah2 and Pias E3-ligases modulates Pias-dependent activation. Oncogene, 26(46), 6665-6676.
40. Desterro, J. M.; Rodriguez, M. S.; Kemp, G. D.; Hay, R. T. (1999). Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1. Journal of Biological Chemistry, 274(15), 10618-10624.
41. Desterro, J. M.; Thomson, J.; Hay, R. T. (1997). Ubch9 conjugates SUMO but not ubiquitin. FEBS Letters, 417(3), 297-300.
42. Di Bacco, A.; Ouyang, J.; Lee, H. Y.; Catic, A.; Ploegh, H.; Gill, G. (2006). The SUMO-specific protease SENP5 is required for cell division. Molecular and Cellular Biology, 26(12), 4489-4498.
43. Dong, M.; Pang, X.; Xu, Y.; Wen, F.; Zhang, Y. (2013). Ubiquitin-conjugating enzyme 9 promotes epithelial ovarian cancer cell proliferation in vitro. International Journal of Molecular Sciences, 14(6), 11061-11071.
44. Dorval, V.; Mazzella, M. J.; Mathews, P. M.; Hay, R. T.; Fraser, P. E. (2007). Modulation of Abeta generation by small ubiquitin-like modifiers does not require conjugation to target proteins. Biochemical Journal, 404(2), 309-316.
45. Duda, D. M.; van Waardenburg, R. C.; Borg, L. A.; McGarity, S.; Nourse, A.; Waddell, M. B.; et al. (2007). Structure of a SUMO-binding-motif mimic bound to Smt3p-Ubc9p: conservation of a non-covalent ubiquitin-like protein-E2 complex as a platform for selective interactions within a SUMO pathway. Journal of Molecular Biology, 369(3), 619-630.
46. Dutting, E.; Schroder-Kress, N.; Sticht, H.; Enz, R. (2011). SUMO E3 ligases are expressed in the retina and regulate SUMOylation of the metabotropic glutamate receptor 8b. Biochemical Journal, 435(2), 365-371.
47. Erker, Y.; Neyret-Kahn, H.; Seeler, J. S.; Dejean, A.; Atfi, A.; Levy, L. (2013). Arkadia, a novel SUMO-targeted ubiquitin ligase involved in PML degradation. Molecular and Cellular Biology, 33(11), 2163-2177.
48. Evdokimov, E.; Sharma, P.; Lockett, S. J.; Lualdi, M.; Kuehn, M. R. (2008). Loss of SUMO1 in mice affects RanGAP1 localization and formation of PML nuclear bodies, but is not lethal as it can be compensated by SUMO2 or SUMO3. Journal of Cell Science, 121(Pt 24), 4106-4113.
49. Fan, J.; Ren, H.; Fei, E.; Jia, N.; Ying, Z.; Jiang, P.; et al. (2008). Sumoylation is critical for DJ-1 to repress p53 transcriptional activity. FEBS Letters, 582(7), 1151-1156.
50. Fei, E.; Jia, N.; Yan, M.; Ying, Z.; Sun, Q.; Wang, H.; et al. (2006). SUMO-1 modification increases human SOD1 stability and aggregation. Biochemical and Biophysical Research Communications, 347(2), 406-412.
51. Flotho, A.; Melchior, F. (2013). Sumoylation: A regulatory protein modification in health and disease. Annual Review of Biochemistry, 82, 357-385.
52. Galanty, Y.; Belotserkovskaya, R.; Coates, J.; Jackson, S. P. (2012). RNF4, a SUMO-targeted ubiquitin E3 ligase, promotes DNA double-strand break repair. Genes & Development, 26(11), 1179-1195.
53. Galanty, Y.; Belotserkovskaya, R.; Coates, J.; Polo, S.; Miller, K. M.; Jackson, S. P. (2009). Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks. Nature, 462(7275), 935-939.
54. Garcia-Dominguez, M.; Reyes, J. C. (2009). SUMO association with repressor complexes, emerging routes for transcriptional control. Biochimica et Biophysica Acta, 1789(6-8), 451-459.
55. Garcia-Gutierrez, P.; Juarez-Vicente, F.; Gallardo-Chamizo, F.; Charnay, P.; Garcia-Dominguez, M. (2011). The transcription factor Krox20 is an E3 ligase that sumoylates its Nab coregulators. EMBO Reports, 12(10), 1018-1023.
56. Gareau, J. R.; Lima, C. D. (2010). The SUMO pathway: Emerging mechanisms that shape specificity, conjugation and recognition. Nature Reviews Molecular Cell Biology, 11(12), 861-871.
57. Gareau, J. R.; Reverter, D.; Lima, C. D. (2012). Determinants of small ubiquitin-like modifier 1 (SUMO1) protein specificity, E3 ligase, and SUMO-RanGAP1 binding activities of nucleoporin RanBP2. Journal of Biological Chemistry, 287(7), 4740-4751.
58. Geiss-Friedlander, R.; Melchior, F. (2007). Concepts in sumoylation: A decade on. Nature Reviews Molecular Cell Biology, 8(12), 947-956.
59. Geoffroy, M. C.; Hay, R. T. (2009). An additional role for SUMO in ubiquitin-mediated proteolysis. Nature Reviews Molecular Cell Biology, 10(8), 564-568.
60. Girdwood, D.; Bumpass, D.; Vaughan, O. A.; Thain, A.; Anderson, L. A.; Snowden, A. W.; et al. (2003). P300 transcriptional repression is mediated by SUMO modification. Molecular Cell, 11(4), 1043-1054.
61. Golebiowski, F.; Matic, I.; Tatham, M. H.; Cole, C.; Yin, Y.; Nakamura, A.; et al. (2009). System-wide changes to SUMO modifications in response to heat shock. Science Signaling, 2(72), ra24.
62. Gong, L.; Kamitani, T.; Fujise, K.; Caskey, L. S.; Yeh, E. T. (1997). Preferential interaction of sentrin with a ubiquitin-conjugating enzyme, Ubc9. Journal of Biological Chemistry, 272(45), 28198-28201.
63. Gong, L.; Millas, S.; Maul, G. G.; Yeh, E. T. (2000). Differential regulation of sentrinized proteins by a novel sentrin-specific protease. Journal of Biological Chemistry, 275(5), 3355-3359.
64. Gong, L.; Yeh, E. T. (2006). Characterization of a family of nucleolar SUMO-specific proteases with preference for SUMO-2 or SUMO-3. Journal of Biological Chemistry, 281(23), 15869-15877.
65. Guo, C.; Hildick, K. L.; Luo, J.; Dearden, L.; Wilkinson, K. A.; Henley, J. M. (2013). SENP3-mediated deSUMOylation of dynamin-related protein 1 promotes cell death following ischaemia. EMBO Journal, 32(11), 1514-1528.
66. Guo, D.; Li, M.; Zhang, Y.; Yang, P.; Eckenrode, S.; Hopkins, D.; et al. (2004). A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. Nature Genetics, 36(8), 837-841.
67. Guzzo, C. M.; Berndsen, C. E.; Zhu, J.; Gupta, V.; Datta, A.; Greenberg, R. A.; et al. (2012). RNF4-dependent hybrid SUMO-ubiquitin chains are signals for RAP80 and thereby mediate the recruitment of BRCA1 to sites of DNA damage. Science Signaling, 5(253), ra88.
68. Hamada, M.; Haeger, A.; Jeganathan, K. B.; van Ree, J. H.; Malureanu, L.; Walde, S.; et al. (2011). Ran-dependent docking of importin-beta to RanBP2/Nup358 filaments is essential for protein import and cell viability. Journal of Cell Biology, 194(4), 597-612.
69. Hang, J.; Dasso, M. (2002). Association of the human SUMO-1 protease SENP2 with the nuclear pore. Journal of Biological Chemistry, 277(22), 19961-19966.
70. Harder, Z.; Zunino, R.; McBride, H. (2004). Sumo1 conjugates mitochondrial substrates and participates in mitochondrial fission. Current Biology, 14(4), 340-345.
71. Hattersley, N.; Shen, L.; Jaffray, E. G.; Hay, R. T. (2011). The SUMO protease SENP6 is a direct regulator of PML nuclear bodies. Molecular Biology of the Cell, 22(1), 78-90.
72. Hay, R. T. (2007). SUMO-specific proteases: A twist in the tail. Trends in Cell Biology, 17(8), 370-376.
73. Heaton, P. R.; Deyrieux, A. F.; Bian, X. L.; Wilson, V. G. (2011). HPV E6 proteins target Ubc9, the SUMO conjugating enzyme. Virus Research, 158(1-2), 199-208.
74. Hecker, C. M.; Rabiller, M.; Haglund, K.; Bayer, P.; Dikic, I. (2006). Specification of SUMO1- and SUMO2-interacting motifs. Journal of Biological Chemistry, 281(23), 16117-16127.
75. Hickey, C. M.; Wilson, N. R.; Hochstrasser, M. (2012). Function and regulation of SUMO proteases. Nature Reviews Molecular Cell Biology, 13(12), 755-766.
76. Hietakangas, V.; Anckar, J.; Blomster, H. A.; Fujimoto, M.; Palvimo, J. J.; Nakai, A.; et al. (2006). PDSM, a motif for phosphorylation-dependent SUMO modification. Proceedings of National Academy of Sciences of the United States of America, 103(1), 45-50.
77. Hochstrasser, M. (2001). SP-RING for SUMO: New functions bloom for a ubiquitin-like protein. Cell, 107(1), 5-8.
78. Hoefer, J.; Schafer, G.; Klocker, H.; Erb, H. H.; Mills, I. G.; Hengst, L.; et al. (2012). PIAS1 is increased in human prostate cancer and enhances proliferation through inhibition of p21. American Journal of Pathology, 180(5), 2097-2107.
79. Hsieh, Y. L.; Kuo, H. Y.; Chang, C. C.; Naik, M. T.; Liao, P. H.; Ho, C. C.; et al. (2013). Ubc9 acetylation modulates distinct SUMO target modification and hypoxia response. EMBO Journal, 32(6), 791-804.
80. Huang, C.; Han, Y.; Wang, Y.; Sun, X.; Yan, S.; Yeh, E. T.; et al. (2009). SENP3 is responsible for HIF-1 transactivation under mild oxidative stress via p300 de-SUMOylation. EMBO Journal, 28(18), 2748-2762.
81. Hudson, J. J.; Chiang, S. C.; Wells, O. S.; Rookyard, C.; El-Khamisy, S. F. (2012). SUMO modification of the neuroprotective protein TDP1 facilitates chromosomal single-strand break repair. Nature Communications, 3, 733.
82. Ihara, M.; Yamamoto, H.; Kikuchi, A. (2005). SUMO-1 modification of PIASy, an E3 ligase, is necessary for PIASy-dependent activation of Tcf-4. Molecular and Cellular Biology, 25(9), 3506-3518.
83. Irwin, S.; Vandelft, M.; Pinchev, D.; Howell, J. L.; Graczyk, J.; Orr, H. T.; et al. (2005). RNA association and nucleocytoplasmic shuttling by ataxin-1. Journal of Cell Science, 118(Pt 1), 233-242.
84. Itahana, Y.; Yeh, E. T.; Zhang, Y. (2006). Nucleocytoplasmic shuttling modulates activity and ubiquitination-dependent turnover of SUMO-specific protease 2. Molecular and Cellular Biology, 26(12), 4675-4689.
85. Jackson, S. P.; Durocher, D. (2013). Regulation of DNA damage responses by ubiquitin and SUMO. Molecular Cell, 49(5), 795-807.
86. Janer, A.; Werner, A.; Takahashi-Fujigasaki, J.; Daret, A.; Fujigasaki, H.; Takada, K.; et al. (2010). SUMOylation attenuates the aggregation propensity and cellular toxicity of the polyglutamine expanded ataxin-7. Human Molecular Genetics, 19(1), 181-195.
87. Johnson, E. S.; Blobel, G. (1997). Ubc9p is the conjugating enzyme for the ubiquitin-like protein Smt3p. Journal of Biological Chemistry, 272(43), 26799-26802.
88. Johnson, E. S.; Blobel, G. (1999). Cell cycle-regulated attachment of the ubiquitin-related protein SUMO to the yeast septins. Journal of Cell Biology, 147(5), 981-994.
89. Johnson, E. S.; Gupta, A. A. (2001). An E3-like factor that promotes SUMO conjugation to the yeast septins. Cell, 106(6), 735-744.
90. Johnson, E. S.; Schwienhorst, I.; Dohmen, R. J.; Blobel, G. (1997). The ubiquitin-like protein Smt3p is activated for conjugation to other proteins by an Aos1p/Uba2p heterodimer. EMBO Journal, 16(18), 5509-5519.
91. Joseph, J.; Tan, S. H.; Karpova, T. S.; McNally, J. G.; Dasso, M. (2002). SUMO-1 targets RanGAP1 to kinetochores and mitotic spindles. Journal of Cell Biology, 156(4), 595-602.
92. Kahyo, T.; Nishida, T.; Yasuda, H. (2001). Involvement of PIAS1 in the sumoylation of tumor suppressor p53. Molecular Cell, 8(3), 713-718.
93. Kim, J. H.; Baek, S. H. (2009). Emerging roles of desumoylating enzymes. Biochimica et Biophysica Acta, 1792(3), 155-162.
94. Kim, K. I.; Baek, S. H.; Chung, C. H. (2002). Versatile protein tag, SUMO: Its enzymology and biological function. Journal of Cellular Physiology, 191(3), 257-268.
95. Kim, Y. M.; Jang, W. H.; Quezado, M. M.; Oh, Y.; Chung, K. C.; Junn, E.; et al. (2011). Proteasome inhibition induces alpha-synuclein SUMOylation and aggregate formation. Journal of the Neurological Sciences, 307(1-2), 157-161.
96. Kim, Y. H.; Sung, K. S.; Lee, S. J.; Kim, Y. O.; Choi, C. Y.; Kim, Y. (2005). Desumoylation of homeodomain-interacting protein kinase 2 (HIPK2) through the cytoplasmic-nuclear shuttling of the SUMO-specific protease SENP1. FEBS Letters, 579(27), 6272-6278.
97. Klug, H.; Xaver, M.; Chaugule, V. K.; Koidl, S.; Mittler, G.; Klein, F.; et al. (2013). Ubc9 sumoylation controls SUMO chain formation and meiotic synapsis in Saccharomyces cerevisiae. Molecular Cell, 50(5), 625-636.
98. Knipscheer, P.; Flotho, A.; Klug, H.; Olsen, J. V.; van Dijk, W. J.; Fish, A.; et al. (2008). Ubc9 sumoylation regulates SUMO target discrimination. Molecular Cell, 31(3), 371-382.
99. Knipscheer, P.; van Dijk, W. J.; Olsen, J. V.; Mann, M.; Sixma, T. K. (2007). Noncovalent interaction between Ubc9 and SUMO promotes SUMO chain formation. EMBO Journal, 26(11), 2797-2807.
100. Kolli, N.; Mikolajczyk, J.; Drag, M.; Mukhopadhyay, D.; Moffatt, N.; Dasso, M.; et al. (2010). Distribution and paralogue specificity of mammalian deSUMOylating enzymes. Biochemical Journal, 430(2), 335-344.
101. Komander, D.; Rape, M. (2012). The ubiquitin code. Annual Review of Biochemistry, 81, 203-229.
102. Kotaja, N.; Karvonen, U.; Janne, O. A.; Palvimo, J. J. (2002). PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Molecular and Cellular Biology, 22(14), 5222-5234.
103. Krumova, P.; Meulmeester, E.; Garrido, M.; Tirard, M.; Hsiao, H. H.; Bossis, G.; et al. (2011). Sumoylation inhibits alpha-synuclein aggregation and toxicity. Journal of Cell Biology, 194(1), 49-60.
104. Krumova, P.; Weishaupt, J. H. (2013). Sumoylation in neurodegenerative diseases. Cellular and Molecular Life Sciences, 70(12), 2123-2138.
105. Kuo, M. L.; den Besten, W.; Thomas, M. C.; Sherr, C. J. (2008). Arf-induced turnover of the nucleolar nucleophosmin-associated SUMO-2/3 protease Senp3. Cell Cycle, 7(21), 3378-3387.
106. Lallemand-Breitenbach, V.; Jeanne, M.; Benhenda, S.; Nasr, R.; Lei, M.; Peres, L.; et al. (2008). Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway. Nature Cell Biology, 10(5), 547-555.
107. Lamoliatte, F.; Bonneil, E.; Durette, C.; Caron-Lizotte, O.; Wildemann, D.; Zerweck, J.; et al. (2013). Targeted identification of SUMOylation sites in human proteins using affinity enrichment and paralog-specific reporter ions. Molecular & Cellular Proteomics. doi: 10.1074/mcp.M112.025569.
108. Lee, M. H.; Mabb, A. M.; Gill, G. B.; Yeh, E. T.; Miyamoto, S. (2011a). NF-kappaB induction of the SUMO protease SENP2: A negative feedback loop to attenuate cell survival response to genotoxic stress. Molecular Cell, 43(2), 180-191.
109. Lee, Y. J.; Miyake, S.; Wakita, H.; McMullen, D. C.; Azuma, Y.; Auh, S.; et al. (2007). Protein SUMOylation is massively increased in hibernation torpor and is critical for the cytoprotection provided by ischemic preconditioning and hypothermia in SHSY5Y cells. Journal of Cerebral Blood Flow and Metabolism, 27(5), 950-962.
110. Lee, Y. J.; Mou, Y.; Maric, D.; Klimanis, D.; Auh, S.; Hallenbeck, J. M. (2011b). Elevated global SUMOylation in Ubc9 transgenic mice protects their brains against focal cerebral ischemic damage. PLoS ONE, 6(10), e25852.
111. Lee, J. H.; Park, S. M.; Kim, O. S.; Lee, C. S.; Woo, J. H.; Park, S. J.; et al. (2009). Differential SUMOylation of LXRalpha and LXRbeta mediates transrepression of STAT1 inflammatory signaling in IFN-gamma-stimulated brain astrocytes. Molecular Cell, 35(6), 806-817.
112. Leitao, B. B.; Jones, M. C.; Brosens, J. J. (2011). The SUMO E3-ligase PIAS1 couples reactive oxygen species-dependent JNK activation to oxidative cell death. FASEB J, 25(10), 3416-3425.
113. Li, W.; Bengtson, M. H.; Ulbrich, A.; Matsuda, A.; Reddy, V. A.; Orth, A.; et al. (2008). Genome-wide and functional annotation of human E3 ubiquitin ligases identifies MULAN, a mitochondrial E3 that regulates the organelle's dynamics and signaling. PLoS ONE, 3(1), e1487.
114. Li, S. J.; Hochstrasser, M. (1999). A new protease required for cell-cycle progression in yeast. Nature, 398(6724), 246-251.
115. Li, S. J.; Hochstrasser, M. (2000). The yeast ULP2 (SMT4) gene encodes a novel protease specific for the ubiquitin-like Smt3 protein. Molecular and Cellular Biology, 20(7), 2367-2377.
116. Li, S. J.; Hochstrasser, M. (2003). The Ulp1 SUMO isopeptidase: Distinct domains required for viability, nuclear envelope localization, and substrate specificity. Journal of Cell Biology, 160(7), 1069-1081.
117. Li, Z.; Hu, Q.; Zhou, M.; Vandenbrink, J.; Li, D.; Menchyk, N.; et al. (2013a). Heterologous expression of OsSIZ1, a rice SUMO E3 ligase, enhances broad abiotic stress tolerance in transgenic creeping bentgrass. Plant Biotechnology Journal, 11(4), 432-445.
118. Li, H.; Niu, H.; Peng, Y.; Wang, J.; He, P. (2013b). Ubc9 promotes invasion and metastasis of lung cancer cells. Oncology Reports, 29(4), 1588-1594.
119. Li, Y.; Wang, H.; Wang, S.; Quon, D.; Liu, Y. W.; Cordell, B. (2003). Positive and negative regulation of APP amyloidogenesis by sumoylation. Proceedings of National Academy of Sciences of the United States of America, 100(1), 259-264.
120. Lima, C. D.; Reverter, D. (2008). Structure of the human SENP7 catalytic domain and poly-SUMO deconjugation activities for SENP6 and SENP7. Journal of Biological Chemistry, 283(46), 32045-32055.
121. Liu, B.; Mink, S.; Wong, K. A.; Stein, N.; Getman, C.; Dempsey, P. W.; et al. (2004). PIAS1 selectively inhibits interferon-inducible genes and is important in innate immunity. Nature Immunology, 5(9), 891-898.
122. Liu, B.; Shuai, K. (2001). Induction of apoptosis by protein inhibitor of activated Stat1 through c-Jun NH2-terminal kinase activation. Journal of Biological Chemistry, 276(39), 36624-36631.
123. Liu, B.; Yang, Y.; Chernishof, V.; Loo, R. R.; Jang, H.; Tahk, S.; et al. (2007). Proinflammatory stimuli induce IKKalpha-mediated phosphorylation of PIAS1 to restrict inflammation and immunity. Cell, 129(5), 903-914.
124. Liu, B.; Yang, R.; Wong, K. A.; Getman, C.; Stein, N.; Teitell, M. A.; et al. (2005). Negative regulation of NF-kappaB signaling by PIAS1. Molecular and Cellular Biology, 25(3), 1113-1123.
125. Loftus, L. T.; Gala, R.; Yang, T.; Jessick, V. J.; Ashley, M. D.; Ordonez, A. N.; et al. (2009). Sumo-2/3-ylation following in vitro modeled ischemia is reduced in delayed ischemic tolerance. Brain Research, 1272, 71-80.
126. Loriol, C.; Parisot, J.; Poupon, G.; Gwizdek, C.; Martin, S. (2012). Developmental regulation and spatiotemporal redistribution of the sumoylation machinery in the rat central nervous system. PLoS ONE, 7(3), e33757.
127. Mahajan, R.; Gerace, L.; Melchior, F. (1998). Molecular characterization of the SUMO-1 modification of RanGAP1 and its role in nuclear envelope association. Journal of Cell Biology, 140(2), 259-270.
128. Martin, S.; Nishimune, A.; Mellor, J. R.; Henley, J. M. (2007). SUMOylation regulates kainate-receptor-mediated synaptic transmission. Nature, 447(7142), 321-325.
129. Masters, C. L.; Multhaup, G.; Simms, G.; Pottgiesser, J.; Martins, R. N.; Beyreuther, K. (1985). Neuronal origin of a cerebral amyloid: Neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO Journal, 4(11), 2757-2763.
130. Matic, I.; Macek, B.; Hilger, M.; Walther, T. C.; Mann, M. (2008a). Phosphorylation of SUMO-1 occurs in vivo and is conserved through evolution. Journal of Proteome Research, 7(9), 4050-4057.
131. Matic, I.; Schimmel, J.; Hendriks, I. A.; van Santen, M. A.; van de Rijke, F.; van Dam, H.; et al. (2010). Site-specific identification of SUMO-2 targets in cells reveals an inverted SUMOylation motif and a hydrophobic cluster SUMOylation motif. Molecular Cell, 39(4), 641-652.
132. Matic, I.; van Hagen, M.; Schimmel, J.; Macek, B.; Ogg, S. C.; Tatham, M. H.; et al. (2008b). In vivo identification of human small ubiquitin-like modifier polymerization sites by high accuracy mass spectrometry and an in vitro to in vivo strategy. Molecular and Cellular Proteomics, 7(1), 132-144.
133. Meulmeester, E.; Kunze, M.; Hsiao, H. H.; Urlaub, H.; Melchior, F. (2008). Mechanism and consequences for paralog-specific sumoylation of ubiquitin-specific protease 25. Molecular Cell, 30(5), 610-619.
134. Mo, Y. Y.; Moschos, S. J. (2005). Targeting Ubc9 for cancer therapy. Expert Opinion of Therapeutic Targets, 9(6), 1203-1216.
135. Mohideen, F.; Capili, A. D.; Bilimoria, P. M.; Yamada, T.; Bonni, A.; Lima, C. D. (2009). A molecular basis for phosphorylation-dependent SUMO conjugation by the E2 UBC9. Nature Structural & Molecular Biology, 16(9), 945-952.
136. Morris, J. R.; Boutell, C.; Keppler, M.; Densham, R.; Weekes, D.; Alamshah, A.; et al. (2009). The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress. Nature, 462(7275), 886-890.
137. Moschos, S. J.; Jukic, D. M.; Athanassiou, C.; Bhargava, R.; Dacic, S.; Wang, X.; et al. (2010). Expression analysis of Ubc9, the single small ubiquitin-like modifier (SUMO) E2 conjugating enzyme, in normal and malignant tissues. Human Pathology, 41(9), 1286-1298.
138. Moschos, S. J.; Smith, A. P.; Mandic, M.; Athanassiou, C.; Watson-Hurst, K.; Jukic, D. M.; et al. (2007). SAGE and antibody array analysis of melanoma-infiltrated lymph nodes: Identification of Ubc9 as an important molecule in advanced-stage melanomas. Oncogene, 26(29), 4216-4225.
139. Mossessova, E.; Lima, C. D. (2000). Ulp1-SUMO crystal structure and genetic analysis reveal conserved interactions and a regulatory element essential for cell growth in yeast. Molecular Cell, 5(5), 865-876.
140. Mukherjee, S.; Thomas, M.; Dadgar, N.; Lieberman, A. P.; Iniguez-Lluhi, J. A. (2009). Small ubiquitin-like modifier (SUMO) modification of the androgen receptor attenuates polyglutamine-mediated aggregation. Journal of Biological Chemistry, 284(32), 21296-21306.
141. Mukhopadhyay, D.; Arnaoutov, A.; Dasso, M. (2010). The SUMO protease SENP6 is essential for inner kinetochore assembly. Journal of Cell Biology, 188(5), 681-692.
142. Mukhopadhyay, D.; Ayaydin, F.; Kolli, N.; Tan, S. H.; Anan, T.; Kametaka, A.; et al. (2006). SUSP1 antagonizes formation of highly SUMO2/3-conjugated species. Journal of Cell Biology, 174(7), 939-949.
143. Mukhopadhyay, D.; Dasso, M. (2007). Modification in reverse: The SUMO proteases. Trends in Biochemical Sciences, 32(6), 286-295.
144. Mullen, J. R.; Brill, S. J. (2008). Activation of the Slx5-Slx8 ubiquitin ligase by poly-small ubiquitin-like modifier conjugates. Journal of Biological Chemistry, 283(29), 19912-19921.
145. Nacerddine, K.; Lehembre, F.; Bhaumik, M.; Artus, J.; Cohen-Tannoudji, M.; Babinet, C.; et al. (2005). The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice. Developmental Cell, 9(6), 769-779.
146. Novatchkova, M.; Bachmair, A.; Eisenhaber, B.; Eisenhaber, F. (2005). Proteins with two SUMO-like domains in chromatin-associated complexes: The RENi (Rad60-Esc2-NIP45) family. BMC Bioinformatics, 6, 22.
147. Okuma, T.; Honda, R.; Ichikawa, G.; Tsumagari, N.; Yasuda, H. (1999). In vitro SUMO-1 modification requires two enzymatic steps, E1 and E2. Biochemical and Biophysical Research Communications, 254(3), 693-698.
148. Ouyang, J.; Shi, Y.; Valin, A.; Xuan, Y.; Gill, G. (2009). Direct binding of CoREST1 to SUMO-2/3 contributes to gene-specific repression by the LSD1/CoREST1/HDAC complex. Molecular Cell, 34(2), 145-154.
149. Owerbach, D.; McKay, E. M.; Yeh, E. T.; Gabbay, K. H.; Bohren, K. M. (2005). A proline-90 residue unique to SUMO-4 prevents maturation and sumoylation. Biochemical and Biophysical Research Communications, 337(2), 517-520.
150. Panse, V. G.; Kuster, B.; Gerstberger, T.; Hurt, E. (2003). Unconventional tethering of Ulp1 to the transport channel of the nuclear pore complex by karyopherins. Nature Cell Biology, 5(1), 21-27.
151. Pedrioli, P. G.; Raught, B.; Zhang, X. D.; Rogers, R.; Aitchison, J.; Matunis, M.; et al. (2006). Automated identification of SUMOylation sites using mass spectrometry and SUMmOn pattern recognition software. Nature Methods, 3(7), 533-539.
152. Pelisch, F.; Gerez, J.; Druker, J.; Schor, I. E.; Munoz, M. J.; Risso, G.; et al. (2010). The serine/arginine-rich protein SF2/ASF regulates protein sumoylation. Proceedings of National Academy of Sciences of the United States of America, 107(37), 16119-16124.
153. Perry, J.; Kleckner, N.; Borner, G. V. (2005). Bioinformatic analyses implicate the collaborating meiotic crossover/chiasma proteins Zip2, Zip3, and Spo22/Zip4 in ubiquitin labeling. Proceedings of National Academy of Sciences of the United States of America, 102(49), 17594-17599.
154. Picard, N.; Caron, V.; Bilodeau, S.; Sanchez, M.; Mascle, X.; Aubry, M.; et al. (2012). Identification of estrogen receptor beta as a SUMO-1 target reveals a novel phosphorylated sumoylation motif and regulation by glycogen synthase kinase 3beta. Molecular and Cellular Biology, 32(14), 2709-2721.
155. Pichler, A.; Gast, A.; Seeler, J. S.; Dejean, A.; Melchior, F. (2002). The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell, 108(1), 109-120.
156. Pichler, A.; Knipscheer, P.; Oberhofer, E.; van Dijk, W. J.; Korner, R.; Olsen, J. V.; et al. (2005). SUMO modification of the ubiquitin-conjugating enzyme E2-25K. Nature Structural & Molecular Biology, 12(3), 264-269.
157. Pichler, A.; Knipscheer, P.; Saitoh, H.; Sixma, T. K.; Melchior, F. (2004). The RanBP2 SUMO E3 ligase is neither HECT- nor RING-type. Nature Structural & Molecular Biology, 11(10), 984-991.
158. Pickart, C. M. (2001). Mechanisms underlying ubiquitination. Annual Review of Biochemistry, 70, 503-533.
159. Pilla, E.; Moller, U.; Sauer, G.; Mattiroli, F.; Melchior, F.; Geiss-Friedlander, R. (2012). A novel SUMO1-specific interacting motif in dipeptidyl peptidase 9 (DPP9) that is important for enzymatic regulation. Journal of Biological Chemistry, 287(53), 44320-44329.
160. Pinto, M. P.; Carvalho, A. F.; Grou, C. P.; Rodriguez-Borges, J. E.; Sa-Miranda, C.; Azevedo, J. E. (2012). Heat shock induces a massive but differential inactivation of SUMO-specific proteases. Biochimica et Biophysica Acta, 1823(10), 1958-1966.
161. Plant, L. D.; Dowdell, E. J.; Dementieva, I. S.; Marks, J. D.; Goldstein, S. A. (2011). SUMO modification of cell surface Kv2.1 potassium channels regulates the activity of rat hippocampal neurons. Journal of General Physiology, 137(5), 441-454.
162. Plechanovova, A.; Jaffray, E. G.; Tatham, M. H.; Naismith, J. H.; Hay, R. T. (2012). Structure of a RING E3 ligase and ubiquitin-loaded E2 primed for catalysis. Nature, 489(7414), 115-120.
163. Potts, P. R. (2009). The Yin and Yang of the MMS21-SMC5/6 SUMO ligase complex in homologous recombination. DNA Repair (Amst), 8(4), 499-506.
164. Potts, P. R.; Yu, H. (2005). Human MMS21/NSE2 is a SUMO ligase required for DNA repair. Molecular and Cellular Biology, 25(16), 7021-7032.
165. Poulsen, S. L.; Hansen, R. K.; Wagner, S. A.; van Cuijk, L.; van Belle, G. J.; Streicher, W.; et al. (2013). RNF111/Arkadia is a SUMO-targeted ubiquitin ligase that facilitates the DNA damage response. Journal of Cell Biology, 201(6), 797-807.
166. Pountney, D. L.; Huang, Y.; Burns, R. J.; Haan, E.; Thompson, P. D.; Blumbergs, P. C.; et al. (2003). SUMO-1 marks the nuclear inclusions in familial neuronal intranuclear inclusion disease. Experimental Neurology, 184(1), 436-446.
167. Pountney, D. L.; Raftery, M. J.; Chegini, F.; Blumbergs, P. C.; Gai, W. P. (2008). NSF, Unc-18-1, dynamin-1 and HSP90 are inclusion body components in neuronal intranuclear inclusion disease identified by anti-SUMO-1-immunocapture. Acta Neuropathologica, 116(6), 603-614.
168. Praefcke, G. J.; Hofmann, K.; Dohmen, R. J. (2012). SUMO playing tag with ubiquitin. Trends in Biochemical Sciences, 37(1), 23-31.
169. Prudden, J.; Pebernard, S.; Raffa, G.; Slavin, D. A.; Perry, J. J.; Tainer, J. A.; et al. (2007). SUMO-targeted ubiquitin ligases in genome stability. EMBO Journal, 26(18), 4089-4101.
170. Prudden, J.; Perry, J. J.; Arvai, A. S.; Tainer, J. A.; Boddy, M. N. (2009). Molecular mimicry of SUMO promotes DNA repair. Nature Structural & Molecular Biology, 16(5), 509-516.
171. Prudden, J.; Perry, J. J.; Nie, M.; Vashisht, A. A.; Arvai, A. S.; Hitomi, C.; et al. (2011). DNA repair and global sumoylation are regulated by distinct Ubc9 noncovalent complexes. Molecular and Cellular Biology, 31(11), 2299-2310.
172. Psakhye, I.; Jentsch, S. (2012). Protein group modification and synergy in the SUMO pathway as exemplified in DNA repair. Cell, 151(4), 807-820.
173. Qu, J.; Liu, G. H.; Wu, K.; Han, P.; Wang, P.; Li, J.; et al. (2007). Nitric oxide destabilizes Pias3 and regulates sumoylation. PLoS ONE, 2(10), e1085.
174. Rajendra, R.; Malegaonkar, D.; Pungaliya, P.; Marshall, H.; Rasheed, Z.; Brownell, J.; et al. (2004). Topors functions as an E3 ubiquitin ligase with specific E2 enzymes and ubiquitinates p53. Journal of Biological Chemistry, 279(35), 36440-36444.
175. Rawlings, N. D.; Barrett, A. J.; Bateman, A. (2012). MEROPS: The database of proteolytic enzymes, their substrates and inhibitors. Nucleic Acids Res, 40(Database issue), D343-D350.
176. Reverter, D.; Lima, C. D. (2004). A basis for SUMO protease specificity provided by analysis of human Senp2 and a Senp2-SUMO complex. Structure, 12(8), 1519-1531.
177. Reverter, D.; Lima, C. D. (2005). Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex. Nature, 435(7042), 687-692.
178. Reynolds, A.; Qiao, H.; Yang, Y.; Chen, J. K.; Jackson, N.; Biswas, K.; et al. (2013). RNF212 is a dosage-sensitive regulator of crossing-over during mammalian meiosis. Nature Genetics, 45(3), 269-278.
179. Ribet, D.; Hamon, M.; Gouin, E.; Nahori, M. A.; Impens, F.; Neyret-Kahn, H.; et al. (2010). Listeria monocytogenes impairs SUMOylation for efficient infection. Nature, 464(7292), 1192-1195.
180. Riedel, M.; Goldbaum, O.; Wille, M.; Richter-Landsberg, C. (2011). Membrane lipid modification by docosahexaenoic acid (DHA) promotes the formation of alpha-synuclein inclusion bodies immunopositive for SUMO-1 in oligodendroglial cells after oxidative stress. Journal of Molecular Neuroscience, 43(3), 290-302.
181. Riley, B. E.; Zoghbi, H. Y.; Orr, H. T. (2005). SUMOylation of the polyglutamine repeat protein, ataxin-1, is dependent on a functional nuclear localization signal. Journal of Biological Chemistry, 280(23), 21942-21948.
182. Ronen, O.; Malone, J. P.; Kay, P.; Bivens, C.; Hall, K.; Paruchuri, L. P.; et al. (2009). Expression of a novel marker, Ubc9, in squamous cell carcinoma of the head and neck. Head and Neck, 31(7), 845-855.
183. Roscioli, E.; Di Francesco, L.; Bolognesi, A.; Giubettini, M.; Orlando, S.; Harel, A.; et al. (2012). Importin-beta negatively regulates multiple aspects of mitosis including RANGAP1 recruitment to kinetochores. Journal of Cell Biology, 196(4), 435-450.
184. Ross, S.; Best, J. L.; Zon, L. I.; Gill, G. (2002). SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization. Molecular Cell, 10(4), 831-842.
185. Roth, W.; Sustmann, C.; Kieslinger, M.; Gilmozzi, A.; Irmer, D.; Kremmer, E.; et al. (2004). PIASy-deficient mice display modest defects in IFN and Wnt signaling. Journal of Immunology, 173(10), 6189-6199.
186. Rytinki, M. M.; Kaikkonen, S.; Pehkonen, P.; Jaaskelainen, T.; Palvimo, J. J. (2009). PIAS proteins: Pleiotropic interactors associated with SUMO. Cellular and Molecular Life Sciences, 66(18), 3029-3041.
187. Ryu, H.; Azuma, Y. (2010). Rod/Zw10 complex is required for PIASy-dependent centromeric SUMOylation. Journal of Biological Chemistry, 285(42), 32576-32585.
188. Sachdev, S.; Bruhn, L.; Sieber, H.; Pichler, A.; Melchior, F.; Grosschedl, R. (2001). PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes & Development, 15(23), 3088-3103.
189. Saitoh, H.; Hinchey, J. (2000). Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. Journal of Biological Chemistry, 275(9), 6252-6258.
190. Santti, H.; Mikkonen, L.; Anand, A.; Hirvonen-Santti, S.; Toppari, J.; Panhuysen, M.; et al. (2005). Disruption of the murine PIASx gene results in reduced testis weight. Journal of Molecular Endocrinology, 34(3), 645-654.
191. Sapetschnig, A.; Rischitor, G.; Braun, H.; Doll, A.; Schergaut, M.; Melchior, F.; et al. (2002). Transcription factor Sp3 is silenced through SUMO modification by PIAS1. EMBO Journal, 21(19), 5206-5215.
192. Schmidt, D.; Muller, S. (2002). Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity. Proceedings of National Academy of Sciences of the United States of America, 99(5), 2872-2877.
193. Schmidt, D.; Muller, S. (2003). PIAS/SUMO: New partners in transcriptional regulation. Cellular and Molecular Life Sciences, 60(12), 2561-2574.
194. Schulz, S.; Chachami, G.; Kozaczkiewicz, L.; Winter, U.; Stankovic-Valentin, N.; Haas, P.; et al. (2012). Ubiquitin-specific protease-like 1 (USPL1) is a SUMO isopeptidase with essential, non-catalytic functions. EMBO Reports, 13(10), 930-938.
195. Sekiyama, N.; Arita, K.; Ikeda, Y.; Hashiguchi, K.; Ariyoshi, M.; Tochio, H.; et al. (2010). Structural basis for regulation of poly-SUMO chain by a SUMO-like domain of Nip45. Proteins, 78(6), 1491-1502.
196. Shao, R.; Zhang, F. P.; Tian, F.; Anders Friberg, P.; Wang, X.; Sjoland, H.; et al. (2004). Increase of SUMO-1 expression in response to hypoxia: Direct interaction with HIF-1alpha in adult mouse brain and heart in vivo. FEBS Letters, 569(1-3), 293-300.
197. Sharrocks, A. D. (2006). PIAS proteins and transcriptional regulation-more than just SUMO E3 ligases? Genes & Development, 20(7), 754-758.
198. Shen, L. N.; Geoffroy, M. C.; Jaffray, E. G.; Hay, R. T. (2009). Characterization of SENP7, a SUMO-2/3-specific isopeptidase. Biochemical Journal, 421(2), 223-230.
199. Shen, L.; Tatham, M. H.; Dong, C.; Zagorska, A.; Naismith, J. H.; Hay, R. T. (2006). SUMO protease SENP1 induces isomerization of the scissile peptide bond. Nature Structural & Molecular Biology, 13(12), 1069-1077.
200. Shin, E. J.; Shin, H. M.; Nam, E.; Kim, W. S.; Kim, J. H.; Oh, B. H.; et al. (2012). DeSUMOylating isopeptidase: A second class of SUMO protease. EMBO Reports, 13(4), 339-346.
201. Shinbo, Y.; Niki, T.; Taira, T.; Ooe, H.; Takahashi-Niki, K.; Maita, C.; et al. (2006). Proper SUMO-1 conjugation is essential to DJ-1 to exert its full activities. Cell Death and Differentiation, 13(1), 96-108.
202. Silver, H. R.; Nissley, J. A.; Reed, S. H.; Hou, Y. M.; Johnson, E. S. (2011). A role for SUMO in nucleotide excision repair. DNA Repair (Amst), 10(12), 1243-1251.
203. Steffan, J. S.; Agrawal, N.; Pallos, J.; Rockabrand, E.; Trotman, L. C.; Slepko, N.; et al. (2004). SUMO modification of Huntingtin and Huntington's disease pathology. Science, 304(5667), 100-104.
204. Stehmeier, P.; Muller, S. (2009). Phospho-regulated SUMO interaction modules connect the SUMO system to CK2 signaling. Molecular Cell, 33(3), 400-409.
205. Su, Y. F.; Yang, T.; Huang, H.; Liu, L. F.; Hwang, J. (2012). Phosphorylation of Ubc9 by Cdk1 enhances SUMOylation activity. PLoS ONE, 7(4), e34250.
206. Subramaniam, S.; Sixt, K. M.; Barrow, R.; Snyder, S. H. (2009). Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity. Science, 324(5932), 1327-1330.
207. Suh, H. Y.; Kim, J. H.; Woo, J. S.; Ku, B.; Shin, E. J.; Yun, Y.; et al. (2012). Crystal structure of DeSI-1, a novel deSUMOylase belonging to a putative isopeptidase superfamily. Proteins, 80(8), 2099-2104.
208. Swaminathan, S.; Kiendl, F.; Korner, R.; Lupetti, R.; Hengst, L.; Melchior, F. (2004). RanGAP1*SUMO1 is phosphorylated at the onset of mitosis and remains associated with RanBP2 upon NPC disassembly. Journal of Cell Biology, 164(7), 965-971.
209. Tago, K.; Chiocca, S.; Sherr, C. J. (2005). Sumoylation induced by the Arf tumor suppressor: A p53-independent function. Proceedings of National Academy of Sciences of the United States of America, 102(21), 7689-7694.
210. Takahashi, Y.; Iwase, M.; Konishi, M.; Tanaka, M.; Toh-e, A.; Kikuchi, Y. (1999). Smt3, a SUMO-1 homolog, is conjugated to Cdc3, a component of septin rings at the mother-bud neck in budding yeast. Biochemical and Biophysical Research Communications, 259(3), 582-587.
211. Takashima, H.; Boerkoel, C. F.; John, J.; Saifi, G. M.; Salih, M. A.; Armstrong, D.; et al. (2002). Mutation of TDP1, encoding a topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy. Nature Genetics, 32(2), 267-272.
212. Tatham, M. H.; Geoffroy, M. C.; Shen, L.; Plechanovova, A.; Hattersley, N.; Jaffray, E. G.; et al. (2008). RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nature Cell Biology, 10(5), 538-546.
213. Tatham, M. H.; Jaffray, E.; Vaughan, O. A.; Desterro, J. M.; Botting, C. H.; Naismith, J. H.; et al. (2001). Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. Journal of Biological Chemistry, 276(38), 35368-35374.
214. Tatham, M. H.; Kim, S.; Jaffray, E.; Song, J.; Chen, Y.; Hay, R. T. (2005). Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism for SUMO paralog selection. Nature Structural & Molecular Biology, 12(1), 67-74.
215. Terashima, T.; Kawai, H.; Fujitani, M.; Maeda, K.; Yasuda, H. (2002). SUMO-1 co-localized with mutant atrophin-1 with expanded polyglutamines accelerates intranuclear aggregation and cell death. NeuroReport, 13(17), 2359-2364.
216. Tomasi, M. L.; Tomasi, I.; Ramani, K.; Pascale, R. M.; Xu, J.; Giordano, P.; et al. (2012). S-adenosyl methionine regulates ubiquitin-conjugating enzyme 9 protein expression and sumoylation in murine liver and human cancers. Hepatology, 56(3), 982-993.
217. Truong, K.; Lee, T. D.; Chen, Y. (2012). Small ubiquitin-like modifier (SUMO) modification of E1 Cys domain inhibits E1 Cys domain enzymatic activity. Journal of Biological Chemistry, 287(19), 15154-15163.
218. Ueda, H.; Goto, J.; Hashida, H.; Lin, X.; Oyanagi, K.; Kawano, H.; et al. (2002). Enhanced SUMOylation in polyglutamine diseases. Biochemical and Biophysical Research Communications, 293(1), 307-313.
219. Ullmann, R.; Chien, C. D.; Avantaggiati, M. L.; Muller, S. (2012). An acetylation switch regulates SUMO-dependent protein interaction networks. Molecular Cell, 46(6), 759-770.
220. Uzunova, K.; Gottsche, K.; Miteva, M.; Weisshaar, S. R.; Glanemann, C.; Schnellhardt, M.; et al. (2007). Ubiquitin-dependent proteolytic control of SUMO conjugates. Journal of Biological Chemistry, 282(47), 34167-34175.
221. van Niekerk, E. A.; Willis, D. E.; Chang, J. H.; Reumann, K.; Heise, T.; Twiss, J. L. (2007). Sumoylation in axons triggers retrograde transport of the RNA-binding protein La. Proceedings of National Academy of Sciences of the United States of America, 104(31), 12913-12918.
222. Vyas, R.; Kumar, R.; Clermont, F.; Helfricht, A.; Kalev, P.; Sotiropoulou, P.; et al. (2013). RNF4 is required for DNA double-strand break repair in vivo. Cell Death and Differentiation, 20(3), 490-502.
223. Walde, S.; Thakar, K.; Hutten, S.; Spillner, C.; Nath, A.; Rothbauer, U.; et al. (2012). The nucleoporin Nup358/RanBP2 promotes nuclear import in a cargo- and transport receptor-specific manner. Traffic, 13(2), 218-233.
224. Wang, J. (2011). Cardiac function and disease: Emerging role of small ubiquitin-related modifier. Wiley Interdisciplinary Reviews: Systems Biology and Medicine, 3(4), 446-457.
225. Wang, L.; Banerjee, S. (2004). Differential PIAS3 expression in human malignancy. Oncology Reports, 11(6), 1319-1324.
226. Wang, C. Y.; She, J. X. (2008). SUMO4 and its role in type 1 diabetes pathogenesis. Diabetes Metabolism Research and Reviews, 24(2), 93-102.
227. Wang, Q.; Wang, Y.; Chen, L.; He, L.; Li, W.; Jiang, H. (2012). Expression characteristics of the SUMOylation genes SUMO-1 and Ubc9 in the developing testis and ovary of Chinese mitten crab, Eriocheir sinensis. Gene, 501(2), 135-143.
228. Weger, S.; Hammer, E.; Heilbronn, R. (2005). Topors acts as a SUMO-1 E3 ligase for p53 in vitro and in vivo. FEBS Letters, 579(22), 5007-5012.
229. Wei, W.; Yang, P.; Pang, J.; Zhang, S.; Wang, Y.; Wang, M. H.; et al. (2008). A stress-dependent SUMO4 sumoylation of its substrate proteins. Biochemical and Biophysical Research Communications, 375(3), 454-459.
230. Weisshaar, S. R.; Keusekotten, K.; Krause, A.; Horst, C.; Springer, H. M.; Gottsche, K.; et al. (2008). Arsenic trioxide stimulates SUMO-2/3 modification leading to RNF4-dependent proteolytic targeting of PML. FEBS Letters, 582(21-22), 3174-3178.
231. Werner, A.; Flotho, A.; Melchior, F. (2012). The RanBP2/ RanGAP1*SUMO1/Ubc9 complex is a multisubunit SUMO E3 ligase. Molecular Cell, 46(3), 287-298.
232. Wilkinson, K. A.; Henley, J. M. (2010). Mechanisms, regulation and consequences of protein SUMOylation. Biochemistry Journal, 428(2), 133-145.
233. Wong, K. A.; Kim, R.; Christofk, H.; Gao, J.; Lawson, G.; Wu, H. (2004). Protein inhibitor of activated STAT Y (PIASy) and a splice variant lacking exon 6 enhance sumoylation but are not essential for embryogenesis and adult life. Molecular and Cellular Biology, 24(12), 5577-5586.
234. Woods, Y. L.; Xirodimas, D. P.; Prescott, A. R.; Sparks, A.; Lane, D. P.; Saville, M. K. (2004). p14 Arf promotes small ubiquitin-like modifier conjugation of Werners helicase. Journal of Biological Chemistry, 279(48), 50157-50166.
235. Wotton, D.; Merrill, J. C. (2007). Pc2 and SUMOylation. Biochemical Society Transactions, 35(Pt 6), 1401-1404.
236. Wu, J.; Matunis, M. J.; Kraemer, D.; Blobel, G.; Coutavas, E. (1995). Nup358, a cytoplasmically exposed nucleoporin with peptide repeats, Ran-GTP binding sites, zinc fingers, a cyclophilin A homologous domain, and a leucine-rich region. Journal of Biological Chemistry, 270(23), 14209-14213.
237. Wu, F.; Zhu, S.; Ding, Y.; Beck, W. T.; Mo, Y. Y. (2009). MicroRNA-mediated regulation of Ubc9 expression in cancer cells. Clinical Cancer Research, 15(5), 1550-1557.
238. Xie, Y.; Kerscher, O.; Kroetz, M. B.; McConchie, H. F.; Sung, P.; Hochstrasser, M. (2007). The yeast Hex3.Slx8 heterodimer is a ubiquitin ligase stimulated by substrate sumoylation. Journal of Biological Chemistry, 282(47), 34176-34184.
239. Xirodimas, D. P.; Chisholm, J.; Desterro, J. M.; Lane, D. P.; Hay, R. T. (2002). P14ARF promotes accumulation of SUMO-1 conjugated (H)Mdm2. FEBS Letters, 528(1-3), 207-211.
240. Xu, Z.; Au, S. W. (2005). Mapping residues of SUMO precursors essential in differential maturation by SUMO-specific protease, SENP1. Biochemistry Journal, 386(Pt 2), 325-330.
241. Xu, Z.; Lam, L. S.; Lam, L. H.; Chau, S. F.; Ng, T. B.; Au, S. W. (2008). Molecular basis of the redox regulation of SUMO proteases: a protective mechanism of intermolecular disulfide linkage against irreversible sulfhydryl oxidation. FASEB Journal, 22(1), 127-137.
242. Xu, Y.; Zuo, Y.; Zhang, H.; Kang, X.; Yue, F.; Yi, Z.; et al. (2010). Induction of SENP1 in endothelial cells contributes to hypoxia-driven VEGF expression and angiogenesis. Journal of Biological Chemistry, 285(47), 36682-36688.
243. Yan, S.; Sun, X.; Xiang, B.; Cang, H.; Kang, X.; Chen, Y.; et al. (2010). Redox regulation of the stability of the SUMO protease SENP3 via interactions with CHIP and Hsp90. EMBO Journal, 29(22), 3773-3786.
244. Yang, S. H.; Galanis, A.; Witty, J.; Sharrocks, A. D. (2006). An extended consensus motif enhances the specificity of substrate modification by SUMO. EMBO Journal, 25(21), 5083-5093.
245. Yang, S. H.; Jaffray, E.; Hay, R. T.; Sharrocks, A. D. (2003). Dynamic interplay of the SUMO and ERK pathways in regulating Elk-1 transcriptional activity. Molecular Cell, 12(1), 63-74.
246. Yang, X.; Li, H.; Zhou, Z.; Wang, W. H.; Deng, A.; Andrisani, O.; et al. (2009). Plk1-mediated phosphorylation of Topors regulates p53 stability. Journal of Biological Chemistry, 284(28), 18588-18592.
247. Yang, K.; Moldovan, G. L.; Vinciguerra, P.; Murai, J.; Takeda, S.; D'Andrea, A. D. (2011a). Regulation of the Fanconi anemia pathway by a SUMO-like delivery network. Genes & Development, 25(17), 1847-1858.
248. Yang, S. H.; Sharrocks, A. D. (2006). PIASxalpha differentially regulates the amplitudes of transcriptional responses following activation of the ERK and p38 MAPK pathways. Molecular Cell, 22(4), 477-487.
249. Yang, W.; Sheng, H.; Homi, H. M.; Warner, D. S.; Paschen, W. (2008). Cerebral ischemia/stroke and small ubiquitin-like modifier (SUMO) conjugation - A new target for therapeutic intervention? Journal of Neurochemistry, 106(3), 989-999.
250. Yang, W.; Thompson, J. W.; Wang, Z.; Wang, L.; Sheng, H.; Foster, M. W.; et al. (2012). Analysis of oxygen/glucose-deprivation-induced changes in SUMO3 conjugation using SILAC-based quantitative proteomics. Journal of Proteome Research, 11(2), 1108-1117.
251. Yang, Y.; Tse, A. K.; Li, P.; Ma, Q.; Xiang, S.; Nicosia, S. V.; et al. (2011b). Inhibition of androgen receptor activity by histone deacetylase 4 through receptor SUMOylation. Oncogene, 30(19), 2207-2218.
252. Yang, W.; Wang, L.; Roehn, G.; Pearlstein, R. D.; Ali-Osman, F.; Pan, H.; et al. (2013). Small ubiquitin-like modifier 1-3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival. Cancer Science, 104(1), 70-77.
253. Yeh, E. T.; Gong, L.; Kamitani, T. (2000). Ubiquitin-like proteins: new wines in new bottles. Gene, 248(1-2), 1-14.
254. Yin, Y.; Seifert, A.; Chua, J. S.; Maure, J. F.; Golebiowski, F.; Hay, R. T. (2012). SUMO-targeted ubiquitin E3 ligase RNF4 is required for the response of human cells to DNA damage. Genes & Development, 26(11), 1196-1208.
255. Yokoyama, N.; Hayashi, N.; Seki, T.; Pante, N.; Ohba, T.; Nishii, K.; et al. (1995). A giant nucleopore protein that binds Ran/TC4. Nature, 376(6536), 184-188.
256. Youle, R. J.; van der Bliek, A. M. (2012). Mitochondrial fission, fusion, and stress. Science, 337(6098), 1062-1065.
257. Yunus, A. A.; Lima, C. D. (2009). Structure of the Siz/PIAS SUMO E3 ligase Siz1 and determinants required for SUMO modification of PCNA. Molecular Cell, 35(5), 669-682.
258. Zhang, F. P.; Mikkonen, L.; Toppari, J.; Palvimo, J. J.; Thesleff, I.; Janne, O. A. (2008). Sumo-1 function is dispensable in normal mouse development. Molecular and Cellular Biology, 28(17), 5381-5390.
259. Zhang, H.; Saitoh, H.; Matunis, M. J. (2002). Enzymes of the SUMO modification pathway localize to filaments of the nuclear pore complex. Molecular and Cellular Biology, 22(18), 6498-6508.
260. Zhang, Y. Q.; Sarge, K. D. (2008). Sumoylation of amyloid precursor protein negatively regulates Abeta aggregate levels. Biochemical and Biophysical Research Communications, 374(4), 673-678.
261. Zhang, C.; Yuan, X.; Yue, L.; Fu, J.; Luo, L.; Yin, Z. (2010). PIASy interacts with p73alpha and regulates cell cycle in HEK293 cells. Cellular Immunology, 263(2), 235-240.
262. Zhao, X.; Blobel, G. (2005). A SUMO ligase is part of a nuclear multiprotein complex that affects DNA repair and chromosomal organization. Proceedings of National Academy of Sciences of the United States of America, 102(13), 4777-4782.
263. Zhao, X.; Sternsdorf, T.; Bolger, T. A.; Evans, R. M.; Yao, T. P. (2005). Regulation of MEF2 by histone deacetylase 4- and SIRT1 deacetylase-mediated lysine modifications. Molecular and Cellular Biology, 25(19), 8456-8464.
264. Zhao, Z.; Tan, X.; Zhao, A.; Zhu, L.; Yin, B.; Yuan, J.; et al. (2012). microRNA-214-mediated UBC9 expression in glioma. BMB Rep, 45(11), 641-646.
265. Zhou, Y. F.; Liao, S. S.; Luo, Y. Y.; Tang, J. G.; Wang, J. L.; Lei, L. F.; et al. (2013). SUMO-1 modification on K166 of polyQ-expanded ataxin-3 strengthens its stability and increases its cytotoxicity. PLoS ONE, 8(1), e54214.
266. Zhu, S.; Sachdeva, M.; Wu, F.; Lu, Z.; Mo, Y. Y. (2010). Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner. Oncogene, 29(12), 1763-1772.
267. Zhu, J.; Zhu, S.; Guzzo, C. M.; Ellis, N. A.; Sung, K. S.; Choi, C. Y.; et al. (2008). Small ubiquitin-related modifier (SUMO) binding determines substrate recognition and paralog-selective SUMO modification. Journal of Biological Chemistry, 283(43), 29405-29415.
268. Zlatanou, A.; Stewart, G. S. (2010). A PIAS-ed view of DNA double strand break repair focuses on SUMO. DNA Repair (Amst), 9(5), 588-592.
269. Zunino, R.; Braschi, E.; Xu, L.; McBride, H. M. (2009). Translocation of SenP5 from the nucleoli to the mitochondria modulates DRP1-dependent fission during mitosis. Journal of Biological Chemistry, 284(26), 17783-17795.
270. Zunino, R.; Schauss, A.; Rippstein, P.; Andrade-Navarro, M.; McBride, H. M. (2007). The SUMO protease SENP5 is required to maintain mitochondrial morphology and function. Journal of Cell Science, 120(Pt 7), 1178-1188.